Pharmaids Pharmaceuticals Ltd

Mon 7/09/2026,16:1:0 | BSE : PHARMAID

₹30.21-0.88 (-2.83%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 31.00

Previous Close

₹ 31.09

Volume

13277

Mkt Cap ( ₹ Cr)

₹ 106.54

High

₹ 33.39

Low

₹ 30.00

52 Week High

₹ 66.00

52 Week Low

₹ 25.60

Book Value Per Share

₹ 14.04

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Pharmaids Pharmaceuticals Ltd

Your Vote -

Buy

63.64%

Hold

27.27%

Sell

9.09%

63.64%

11 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Pharmaids Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Pharmaids Pharma. - Reg. 34 (1) Annual Report.

    18 Aug 2026, 5:20PM Annual Report
  • Pharmaids Pharma. - Notice Of 37Th Annual General Meeting And Annual Report

    18 Aug 2026, 5:07PM Notice of 37th AGM and Annual Report
  • Pharmaids Pharma. - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2026

    12 Aug 2026, 7:39PM Submission of unaudited financial results
  • Pharmaids Pharma. - Board Meeting Outcome for Board Meeting Outcome For August 12, 2026

    12 Aug 2026, 7:32PM Outcome of the Board meeting held today i.e. August 12, 2026
  • Pharmaids Pharma. - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Co

    6 Aug 2026, 3:30PM Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to con
  • Pharmaids Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    13 Jul 2026, 6:50PM As of June 2026, 32.99% is owned by Indian Promoters and 67.01% by Public. <p align=justify> Top three Promoters holding highest number of shares of P
  • Pharmaids Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2026, 3:23PM Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
  • Pharmaids Pharma. - Announcement under Regulation 30 (LODR)-Change in Management

    30 Jun 2026, 7:17PM Appointment of M/s. V Mahendra & Associates, as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-2
  • Pharmaids Pharma. - Announcement under Regulation 30 (LODR)-Change in Management

    25 Jun 2026, 6:08PM Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform you of t
  • Pharmaids Pharma. - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Providing Corporate Guarantee To Subsid

    13 Jun 2026, 10:10AM Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 - Providing corporate guarantee to subsidiary, Adita Bio Sys Private Limited

Key fundamentals

Evaluate the intrinsic value of Pharmaids Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 73.8327 103.1888 83.5609 22.4252 8.6715
Liabilities 73.8327 103.1888 83.5609 22.4252 8.6715
Equity 35.2678 35.2678 35.2678 21.4438 10.2688
Gross Profit -14.2089 -7.2573 -6.3711 -9.8862 0.137
Net Profit -10.4372 -7.2792 -4.9498 -7.5556 0.1451
Cash From Operating Activities -3.5329 -7.7243 -3.4432 -4.0193 -0.2593
NPM(%) -98.44 -310.95 -17805.03 0 3.68
Revenue 10.6025 2.3409 0.0278 0 3.9392
Expenses 24.8114 9.5982 6.3989 9.8862 3.8021
ROE(%) -21.07 -14.69 -9.99 -15.25 0.29

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Pharmaids Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 858.30 -0.01 21.83 17.74 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 108.55 1.12 1558.00 64.66 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.27 -0.46 0.00 134.25 -39.50 0.00
Astec Lifesciences Ltd 550.00 -0.96 0.00 69.28 -363.14 0.00

Company Info

The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

The Company was incorporated on 1st March, 1989, under the name Pharmaids Pharmaceuticals Pvt Ltd, as a Private Limited Company. The company was converted into Public Limited company on 8th May, 1992. In terms of special resolution dated April 20, 1992 passed u/s 31/44 of the Companies Act, 1956. 2005 -Pharmaids Pharmaceuticals signs Ayurvedic drugs deal. -The Company appointed Mr. Bipin Shah as the Chairman of the Company. 2024 -The Company has entered into Share Purchase Agreement with two existing Public Shareholders of the Company. -The Company has completed the Acquisition of 99.86% shareholding in Adita Bio Sys Private Limited.

Parent Organisation

Pharmaids Pharmaceuticals Ltd.

Founded

01/03/1989

Managing Director

NSE Symbol

FAQ